Skip to content
Recall Observatory FDA recall evidence

Drug product

TRI-LO-MARZIA 0.180MG/0.025MG; 0.215 MG/0.025MG AND 0.250MG/0.025MG 3X28 BPK; NDC/UPC 68180-837-73; RX; TABLETS

D-0508-2021

March 15, 2021

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 87512
Status
Terminated
Classification
Class II
Quantity
60 CARTON
Official record key
drug-enforcement:D-0508-2021

Official wording

Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Code information: L001911

Distribution pattern: FL, GA, SC

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations